Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGateley Holdings Regulatory News (GTLY)

Share Price Information for Gateley Holdings (GTLY)

Share Price is delayed by 15 minutes
Get Live Data
58.00    -1.00 (-1.69%)
Bid:
57.00
Ask:
59.00
Spread: 2.00 (3.509%)
Market Cap: £78.38m
GTLY Live PriceLast checked at - London Stock Exchange

Intraday Gateley Holdings Share Chart

AGM Statement

27 Sep 2017 07:00

RNS Number : 8883R
Gateley (Holdings) PLC
27 September 2017
 

 

27 September 2017

 

Gateley (Holdings) Plc

 

("Gateley" or the "Company" or the "Group")

 

AGM Statement

 

Gateley (AIM:GTLY), the national commercial law and complementary professional services group, is today holding its Annual General Meeting at 12.30pm at the Company's offices at One Eleven, Edmund Street, Birmingham, B3 2HJ. The Non-Executive Chairman, Nigel Payne, will make the following statement at the meeting:

"The Board is pleased to report that the business continues to perform well and is trading in line with management's expectations. Following a year of significant expansion and investment, Gateley continues to achieve solid organic growth, whilst remaining focused on the execution of its stated ambition of seeking complementary acquisitions which are earnings accretive to the Group. Driven by the strength of its service offering, its ability to retain and attract excellent staff and expand on existing client relationships, Gateley remains well placed for the future. Further new recruits have settled in well across the Group including professional staff in Gateley Hamer, Gateley Capitus and across its core national legal divisions.

 

In the last financial year, Gateley has introduced a range of employee share schemes that enable all staff to acquire shares and participate in its long term financial success. We were delighted with the staff response to these schemes and the extent of the staff participation.

 

At the AGM shareholders are being asked today to approve, amongst other things, a final dividend of 4.4 pence per ordinary share, which, if approved, will be paid on 4 October 2017 to those shareholders on the register at the close of business on 8 September 2017. This dividend will result in a total dividend for the year ended 30 April 2017 of 6.6 pence per ordinary share.

 

Finally, the Board notes that today is the last day of Michael Seabrook's term of office as a director of the Company. The Board would like to thank Michael for his service and wish him well for the future. In addition, today we welcome Suki Thompson to the Board and we look forward to benefitting from her experience and working with her."

 

Enquiries:

 

Gateley (Holdings) Plc

Neil Smith, Finance Director

 

Tel: +44 (0) 121 234 0196

Nick Smith, Acquisitions Director and Head of Investor Relations

Tel: +44 (0) 20 7653 1665

Cara Zachariou, Head of Communications

Tel: +44 (0) 121 234 0074 or+44 (0) 7703 684 946

 

 

Cantor Fitzgerald Europe - Nominated adviser and broker

 

David Foreman, Marc Milmo, Callum Butterfield (Corporate Finance)

Tel: +44 (0) 20 7894 7000

Mark Westcott, Alex Pollen, Caspar Shand Kydd (Sales)

 

 

 

Arden Partners - Broker

 

John Llewellyn-Lloyd, Benjamin Cryer (Corporate Finance)

Tel: +44 (0) 20 7614 5900

James Reed-Daunter (Corporate Broking)

 

 

 

IFC Advisory - Financial PR adviser

Tel: +44 (0) 20 3053 8671

Tim Metcalfe, Graham Herring, Miles Nolan

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUNVVRBVAKUAR
Date   Source Headline
26th Jun 20244:57 pmRNSTR-1
12th Jun 20248:11 amRNSIssue of Equity and Total Voting Rights
5th Jun 20243:52 pmRNSTR-1
4th Jun 202410:32 amRNSTR-1
3rd Jun 20244:07 pmRNSTR-1
31st May 20244:45 pmRNSTotal Voting Rights
14th May 20247:00 amRNSTrading Update, Notice of Results and Board Change
5th Apr 20247:00 amRNSEBT Share Purchase / PDMR Dealings
18th Jan 20247:00 amRNSShare Purchase by Incoming Non-Executive Director
17th Jan 20247:00 amRNSSuccession Update: Appointment of Chair Designate
17th Jan 20247:00 amRNSHalf Year Results
22nd Nov 20237:00 amRNSH1 24 Trading update and notice of results
15th Nov 20234:28 pmRNSTR-1
14th Nov 20231:33 pmRNSGrant of SAYE Options and PDMR Dealings
31st Oct 20237:00 amRNSIssue of Equity and Total Voting Rights
18th Oct 20237:01 amRNSResult of AGM
25th Sep 20237:30 amRNSNotice of AGM
22nd Sep 20234:41 pmRNSTR-1
22nd Sep 20234:11 pmRNSBlock listing Six Monthly Review
21st Sep 20232:40 pmRNSShare Awards and Options, Issue of Equity and TVR
15th Sep 20237:00 amRNSPublication of annual Responsible Business report
14th Sep 20237:00 amRNSHolding(s) in Company
11th Sep 20235:00 pmRNSTR-1
8th Sep 20232:56 pmRNSAudited Results 2023 Replacement
6th Sep 20238:51 amRNSTR-1
6th Sep 20237:00 amRNSAppointment of Non-Executive Director
6th Sep 20237:00 amRNSAudited Results 2023
31st Aug 20237:00 amRNSNotice of Final Results
31st Jul 20237:00 amRNSYear end update & notice of annual results and AGM
20th Jul 20237:00 amRNSAcquisition of Richard Julian and Associates Ltd
27th Jun 202310:31 amRNSBoard Change
2nd Jun 20237:00 amRNSFY23 Trading Update
25th May 20239:26 amRNSTR-1
11th May 20232:16 pmRNSTR-1
7th Mar 20232:46 pmRNSTR-1
23rd Feb 20239:37 amRNSGrant of Share Awards, Share Options and TVR
18th Jan 20237:00 amRNSHalf Year Results
16th Jan 20232:04 pmRNSTR-1
12th Dec 20228:00 amRNSSecond Responsible Business Report
24th Nov 20227:00 amRNSTrading update and notice of results
1st Nov 20221:40 pmRNSIssue of Equity, Block Listing and TVRs
20th Oct 20224:02 pmRNSResult of AGM
4th Oct 20227:00 amRNSAcquisition of Symbiosis IP, Issue of Equity & TVR
3rd Oct 20225:14 pmRNSTR-1
26th Sep 20228:00 amRNSNotice of AGM
14th Sep 20227:00 amRNSIssue of Equity and Total Voting Rights
13th Sep 20227:00 amRNSAudited Preliminary Results 2022
5th Sep 20227:00 amRNSNotice of Results and Online Presentations
13th Jun 20227:00 amRNSFY22 Trading Update - Ahead of Expectations
3rd May 20221:22 pmRNSPlanned Succession Board Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.